Fig. 3
From: Induced hypernatremia in patients with moderate-to-severe ARDS: a randomized controlled study
a Plasma Ang-1, (Group p = 0.936, Time p = 0.288, Gp*Time p = 0.480); Ang-2, (Group p = 0.010, Time p = 0.825, Gp*Time p = 0.750); Ang-1:Ang-2, (Group p = 0.116, Time p = 0.343, Gp*Time p = 0.639); IL-6 (Group p = 0.634, Time p = 0.158, Gp*Time p = 0.609); and TNF α (Group p = 0.972, Time p = 0.262, Gp*Time p = 0.556). b Bronchoalveolar lavage Ang-1, (Group p = 0.909, Time p = 0.665, Gp*Time p = 0.812); Ang-2, (Group p = 0.951, Time p = 0.045, Gp*Time p = 0.849); Ang-1:Ang-2, (Group p = 0.876, Time p = 0.376, Gp*Time p = 0.416); IL-6, (Group p = 0.972, Time p ≤ 0.001, Gp*Time p = 0.862); TNF α (Group p = 0.196, Time p = 0.196, Gp*Time p = 0.334); and total protein (Group p = 0.825, Time p = 0.005, Gp*Time p = 0.842) between the groups. There was no difference in these plasma and BAL biomarkers between the groups